According to Bright Minds Biosciences's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 61.1 | 3784.64% |
2023-12-31 | 1.57 | -9.74% |
2022-12-31 | 1.74 | -46.19% |
2021-12-31 | 3.24 | |
2020-12-31 | N/A |